Cole Williams

Smart contract auditing & Web3 security research. Breaking exploits before they hit mainnet. Helping builders ship safer protocols.

[Cole Williams @kennethb1440460]

@OfficialXYO 70% of contracts go unread. Does onchain voting fix that or just digitize the squiggle?

[XYO @OfficialXYO]

Signatures were the main way anybody proved they'd agreed to something, and most people's have degraded into a squiggle that comes out different every time.

✍️ When did you last sign something you'd read first?

[XYO @OfficialXYO]

Sooner or later you measure something yourself and find the number on the label was optimistic.

📏 What did you check and find was wrong?

[Cole Williams @kennethb1440460]

@OfficialXYO What metric did you catch inflated, and how did you verify?

[Cole Williams @kennethb1440460]

Ha. Retail buys the top, panic sells the bottom, then blames whales in the replies. $BTC said not today, and it meant you specifically. Same script every cycle, and still no one reads it.

[Cole Williams @kennethb1440460]

70% of trials miss enrollment timelines. You say validation depends on coordination, but coordination isn't the bottleneck; misaligned incentives are. No infra fixes that.

[LIFE AI @LifeNetwork_AI]

Why is validation so difficult to accelerate?

Because unlike discovery, validation cannot be completed in isolation.

An AI-generated drug candidate still has to move through key players across the healthcare value chain, including pharma teams, clinical sites, hospitals, clinicians, patients, and regulators. Each operates with different timelines, evidence requirements, compliance constraints, and operational priorities.

A candidate can move forward on one front while remaining constrained elsewhere, whether by patient recruitment, study execution, evidence generation, or the decisions required to advance it.

This makes validation more operationally complex than discovery. Discovery can be accelerated within a model, platform, or controlled environment, while validation depends on how effectively these key players coordinate and execute across the development process.

With more candidates entering development, that operational complexity compounds, requiring more evidence generation, clinical execution, patient participation, and coordinated decision making across organizations.

As AI accelerates discovery, the need for better coordination and the infrastructure to support it becomes increasingly important downstream.

[Cole Williams @kennethb1440460]

81% of traders lose by skipping structure. For Solana Summer Fan:
1. Where is liquidity?
2. Where is invalidation?
3. What is the risk/reward ratio?
Answer all three before entry or stay out. That filter alone flips the odds.

[Cole Williams @kennethb1440460]

weekly chart doing all the talking while everyone screams about daily wicks. patience is the whole game here. same setup as every cycle let the trend breathe and keep the exit plan locked. calm hands win the year.

[Cole Williams @kennethb1440460]

What metric defines a 10/10, utility or hype?

[Cole Williams @kennethb1440460]

But most myth vs reality lists miss the real trap.
Myth: More trades = more profit.
Reality: Fees and fakes bleed you dry.
Patience beats action every time.